Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04469764
Title Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Jonsson Comprehensive Cancer Center

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

endometrial carcinoma


Abemaciclib + Anastrozole

Abemaciclib + Letrozole


Age Groups: child | senior | adult
Covered Countries USA

Additional content available in CKB BOOST